According to a new MarketsandMarketsTM study, the Urology Devices Market is expected to reach USD 46.4 billion by 2026, up from USD 38.0 billion in 2021, at a CAGR of 4.1 percent. The increased inclination for minimally invasive treatments, the increasing number of hospitals and investments in endoscopy and laparoscopy facilities, and the rising incidence and prevalence of urological disorders are the primary drivers driving the growth of the urology devices market.
The urological devices market is divided into two categories: instruments and consumables and accessories. The instruments section held the highest share in 2020. This can be ascribed to important players releasing new and enhanced urology devices, as well as the growing inclination for less invasive operations.
The urology devices market is split by application into renal illnesses, urological cancer and BPH, pelvic organ prolapse, and other applications. In 2020, the renal diseases category held the greatest market share. This can be ascribed to an aging population and an increase in the prevalence of renal illnesses.
The urology devices market is divided into hospitals, ASCs and clinics, dialysis facilities, and home care settings based on end users. The hospitals, ASCs, and clinics sectors held the greatest market share in 2020. The increased usage of urology devices and consumables to service the vast patient population is the primary reason driving this segment’s growth.
